Krystal Biotech Inc (KRYS) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access KRYS Annual Balance Sheets →
Balance sheet data covering Krystal Biotech Inc–Jun 30 2025 offers a view into how Jun 30 2026's financial position has changed alongside business activity.
Quarterly Report, GAAP in USD millions
ITEM
(Jun 30 2026)
(Mar 31 2026) (Dec 31 2025) (Sep 30 2025) (Jun 30 2025)
Assets
Cash & cash equivalent845.60
Available-for-sale Securities, Debt Securities, Current MA0.00
Cash & Short-term Investments845.00
Accounts receivable138.66
Inventories45.56
Other Current Assets0.00
Total loans net29.80
Total Current Assets1,059.65
Equipment/Property/Plant Net190.15
Long-term investments257.29
Other Assets, Noncurrent0.00
Operating Lease Right Of Use Asset7.04
Total Assets1,500.65
Liabilities
Accounts Payable, Current AC6.54
Accrued Liabilities, Current4.84
Other Liabilities, Current101.20
Taxes Payable14.81
Total Current Liabilities127.40
Total Long-term Debt0.00
Other liabilities, Noncurrent14.13
Operating Lease Liability Current1.80
Operating Lease Liability Noncurrent7.31
Total Liabilities141.52
Stockholders' Equity
Additional Paid In Capital Common Stock1,228.60
Retained Earnings / Accumulated Deficit134.86
Accumulated Other Comprehensive Income-4.34
Other Equity-4.34
Common Stockholder's Equity1,359.13
Total Stockholder's Equity1,359.13
Liabilities & Stockholder's Equity1,500.65
4 historic quarters locked

Sign in to unlock the full Krystal Biotech Inc balance sheet history.

About Krystal Biotech Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001711279-26-000057

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.